Brauner, E., Gunda, V., Borre, P. V., Zurakowski, D., Kim, Y. S., Dennett, K. V., . . . Parangi, S. (2016). Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer. Oncotarget.

Brauner, Eran, Viswanath Gunda, Pierre Vanden Borre, David Zurakowski, Yon Seon Kim, Kate Virginia Dennett, Salma Amin, Gordon James Freeman, and Sareh Parangi. "Combining BRAF Inhibitor and Anti PD-L1 Antibody Dramatically Improves Tumor Regression and Anti Tumor Immunity in an Immunocompetent Murine Model of Anaplastic Thyroid Cancer." Oncotarget 2016.

Brauner, Eran, et al. "Combining BRAF Inhibitor and Anti PD-L1 Antibody Dramatically Improves Tumor Regression and Anti Tumor Immunity in an Immunocompetent Murine Model of Anaplastic Thyroid Cancer." Oncotarget 2016.